One year following a real life experience of omalizumab for moderate to severe persistent allergic asthma in Malta Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013
Add-on omalizumab in children with severe allergic asthma: a 1-year real life survey Source: Eur Respir J 2013; 42: 1224-1233 Year: 2013
Trends in prevalence of atopic diseases and allergic sensitization in children in Eastern Germany Source: Eur Respir J 2002; 19: 1040-1046 Year: 2002
Is the asthma epidemic in Europe passing by? Source: Annual Congress 2005 - The hygiene hypothesis revised – pro, con, or…? Year: 2005
Trends in asthma, allergic rhinitis and eczema among Swedish conscripts from farming and non-farming environments. A nationwide study over three decades Source: Eur Respir J 2003; 22: Suppl. 45, 564s Year: 2003
Real life experience of omalizumab on selected children with severe allergic asthma Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma Year: 2016
Prevalence of asthma, rhinitis and atopic eczema among children in Athens and Thessaloniki, Greece. (ISAAC, international study of asthma and allergies in childhood) Source: Eur Respir J 2002; 20: Suppl. 38, 316s Year: 2002
Real-life effectiveness of omalizumab in patients with severe persistent allergic (IgE-mediated) asthma at a single UK hospital Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
Changing pattern of asthma admissions in children over 15 years in Galway, Ireland Source: Annual Congress 2006 - Childhood asthma in Europe - is it still increasing and what are the causes? Year: 2006
Social class in asthma and allergic rhinitis: a national cohort study over three decades Source: Eur Respir J 2005; 26: 1064-1068 Year: 2005
Social class, asthma and allergic rhinoconjunctivitis in Swedish conscripts - a national cohort study over three decades Source: Eur Respir J 2004; 24: Suppl. 48, 170s Year: 2004
Is the increase in childhood asthma coming to an end? Findings from three surveys of schoolchildren in Rome, Italy Source: Eur Respir J 2001; 17: 881-886 Year: 2001
Omalizumab in severe uncontrolled asthma: two and a half year clinical experience Source: Annual Congress 2009 - Towards improving asthma control Year: 2009
Increasing prevalence of asthma, allergic rhinoconjunctivitis and eczema among schoolchildren: Three surveys during the period 1985-2008 Source: Annual Congress 2013 –Paediatric respiratory epidemiology: bronchiolitis and asthma Year: 2013
Omalizumab exposure patterns in real-life: An 11-year French population-based study of 19,203 patients with severe asthma. Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021
Traffic exposure associated with allergic asthma and allergic rhinitis in adults. A cross-sectional study in southern Sweden Source: Annual Congress 2009 - Indoor and outdoor air pollution Year: 2009
"It‘s like living with a time bomb"– European patients‘ perspective on severe asthma symptoms Source: Annual Congress 2005 - Severe asthma: perception and management Year: 2005
Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective study Source: Eur Respir J 2003; 21: 116-122 Year: 2003
First months of employment and new onset of rhinitis in adolescents Source: Eur Respir J 2007; 30: 549-555 Year: 2007
Trends in the prevalence of asthma and allergic rhinitis in Italy between 1991 and 2010 Source: Eur Respir J 2012; 39: 883-892 Year: 2012